Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.

Trial Profile

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Eplivanserin (Primary)
  • Indications Insomnia
  • Focus Registrational; Therapeutic Use
  • Acronyms GEMS
  • Sponsors Sanofi
  • Most Recent Events

    • 09 Jun 2009 Actual patient number (967) added as reported by ClinicalTrials.gov.
    • 13 Mar 2008 Status changed from in progress to completedas reported by ClinicalTrials.gov
    • 15 Nov 2007 Eplivanserin is expected to be launched in 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top